Insights & Resources – COD Research

Medical Affairs

CT Quality Assurance

Clinical Services

Biometrics

Transforming Complexity into Success: A Large-Scale Global Phase III Biosimilar Dermatology Trial

Strategic Planning for Patient Recruitment

Pulmonary Disease Introduction: Prevalence, Causes, Prevention & Treatment

EMA
FDA
MHRA

Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 10, Status: Authorised
Source: EMA Published on 2025-05-08
Careers
Source: EMA Published on 2025-05-08
Who we are
Source: EMA Published on 2025-05-08
EMA Gender equality plan 2025 - 2030
Source: EMA Published on 2025-05-08
Human medicines European public assessment report (EPAR): Tuzulby, methylphenidate hydrochloride, Date of authorisation: 28/02/2025, Status: Authorised
Source: EMA Published on 2025-05-08
Opinions and letters of support on the qualification of novel methodologies for medicine development
Source: EMA Published on 2025-05-08

Read More